Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05363046 · ClinicalTrials.gov registry record

Noninterventional Study Evaluating Parkinson's Disease Diary Use

A clinical trial of Parkinson's Disease, sponsored by BlueRock Therapeutics.

Active
Registry status
194
Enrollment target
20
Study locations

NCT05363046 is a study of Parkinson's Disease that is active but no longer recruiting, run by BlueRock Therapeutics. The registered enrollment target is 194 participants, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05363046, a study of Parkinson's Disease, is active but no longer recruiting, sponsored by BlueRock Therapeutics.

ACTIVE NOT RECRUITING
Registry status
194 participants
Enrollment target
20
Study locations

Study Summary

This study aims to evaluate the impact of the frequency of assessments on the variability over time, reliability, and compliance for the Parkinson's disease (PD) diary in patients with PD in whom medications do not provide adequate control of symptoms.

Conditions Studied

Parkinson's Disease

Study Locations (20)

New York

  • Mount Sinai West - New York
  • Weill Cornell Medicine - New York Presbyterian Hospital - New York
  • University of Rochester Medical Center - Rochester

California

  • David Geffen School of Medicine University of California Los Angeles - Los Angeles
  • University of California, Irvine - Orange

Florida

  • Movement Disorders Center of Boca Raton - Boca Raton
  • University of Miami Health System - Miami

Bavaria

  • Klinikum der Universität München - Campus Grosshadern - Munich
  • Technischen Universitaet Muenchen (TUM) - Munich

Arizona

  • Mayo Clinic Neurology - Scottsdale

Colorado

  • University of Colorado - Aurora

Illinois

  • Parkinson's Disease and Movement Disorders Center at Northwestern University Feinberg School of Medicine - Chicago

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2022-07-29
Est. Completion 2026-10

Sponsor

BlueRock Therapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05363046

The ClinicalTrials.gov registry entry for NCT05363046 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (70% lower). The listed sponsor is BlueRock Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT05363046 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, California, Florida.

Frequently Asked Questions

What is clinical trial NCT05363046 about?

NCT05363046 is a clinical study titled "Noninterventional Study Evaluating Parkinson's Disease Diary Use". This study aims to evaluate the impact of the frequency of assessments on the variability over time, reliability, and compliance for the Parkinson's disease (PD) diary in patients with PD in whom medications do not provide adequate control of symptoms.

What is the current status of trial NCT05363046?

This trial is currently active not recruiting. The enrollment target is 194 participants. The study started on 2022-07-29. Estimated completion is 2026-10.

What conditions does trial NCT05363046 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT05363046?

This trial is sponsored by BlueRock Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05363046 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.